Prospective characterization of cognitive function in typical and brainstem predominant progressive supranuclear palsy phenotypes

논문상세정보
    • 저자 Young-Eun C Lee David R Williams Jacqueline F I Anderson
    • 제어번호 105897067
    • 학술지명 Journal Of Movement Disorders
    • 권호사항 Vol. 11 No. 2 [ 2018 ]
    • 발행처 대한파킨슨병및이상운동질환학회
    • 자료유형 학술저널
    • 수록면 72-77 ( 6쪽)
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 강원대학교 춘천캠퍼스 도서관 의학분관 경북대학교 도서관 의학분관
    • 판매처
    유사주제 논문( 0)

' Prospective characterization of cognitive function in typical and brainstem predominant progressive supranuclear palsy phenotypes' 의 참고문헌

  • Wisconsin Card Sorting Test - 64 Card Version
    Kongs SK [2000]
  • Wechsler Memory Scale
    Wechsler D [1997]
  • Wechsler Adult Intelligence Scale
  • The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases
    Respondek G [2014]
  • The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBMDARTEL study
    Agosta F [2010]
  • The Visual Object and Space Battery
  • Subcortical dementia: historical review and personal view
    Albert ML [2005]
  • Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA)
    Bak TH [2005]
  • Rey Auditory Verbal Learning Test: A Handbook
    Schmidt M [1996]
  • Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy
    Williams DR [2007]
  • Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges
    Williams DR [2009]
  • Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome
    Williams DR [2007]
  • Parkinsonism: onset, progression and mortality
    Hoehn MM [1967]
  • Normative data stratified by age and education for two measures of verbal fluency : FAS and animal naming
  • Normative data for the boston naming test for Australian elderly
    Worrall LE [1995]
  • Normative data for the Tower of London performance in Australian midlife women
    Lee YC [2013]
  • Neuropathology of variants of progressive supranuclear palsy
    Dickson DW [2010]
  • Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy
  • Individual differences in trajectory of intellectual development over 45 years of adulthood
    Arbuckle TY [1998]
  • In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism
    Srulijes K [2011]
  • Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses
    Park HK [2009]
  • Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy
  • Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease
    Zhang J [2016]
  • Demographic influences on baseline and derived scores from the Trail Making Test in healthy older Australian adults
    Hester RL [2005]
  • Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy
  • Cognitive impairment, no dementia: concepts and issues
    Tuokko HA [2001]
  • Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage
    Caso F [2016]
  • Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes
    Monza D [1998]
  • Clinical features and criteria for the diagnosis of progressive supranuclear palsy
    Williams DR [2012]
  • Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy
    Ahmed Z [2008]
  • Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
    Williams DR [2005]
  • Aging and response inhibition: normative data for the Victoria Stroop
    Troyer AK [2006]
  • A clinical rating scale for progressive supranuclear palsy
    Golbe LI [2007]